EN
DE
ZH
M+W Group to build RB’s new Centre for Scientific Excellence, Kingston upon Hull, UK
RB, (formerly Reckitt Benckiser) has appointed leading global engineering and construction company M+W Group, as the main contractor to design and build its state-of-the-art R&D Centre for Scientific Excellence (CfSE) in Kingston upon Hull (Hull).
RB, the world’s leading consumer health and hygiene company, has been present in Hull since 1840. The new £105m development is the single largest investment in the company’s history and represents a significant commitment to RB’s place in the heart of the city.
Designed to be highly sustainable and energy efficient, the CfSE will house a new industry-leading Good Manufacturing Practice (GMP) healthcare development facility. It will feature a number of product development capabilities including analytical, formulation and microbiology laboratories plus a stability testing unit. These will support the creation and testing of cutting-edge innovations focused on meeting consumer’s health needs for leading brands such as Strepsils, Gaviscon and Nurofen.
Sharon James, Senior Vice President, RB R&D described the appointment as a milestone in the history of the Centre for Scientific Excellence. “The new Centre for Scientific Excellence is an ambitious project that will transform our R&D facility in Hull. We’re delighted to announce the appointment of M+W Group. It heralds the beginning of the construction phase of the development, which is incredibly exciting for everyone involved, as well as the city of Hull and the wider Humber region.”
Spencer Baber, UK Managing Director, M+W Group said, “M+W Group is delighted to have been selected as RB’s partner to deliver the new Centre for Scientific Excellence. This new facility will be an innovation hub, enabling RB to carry out industry-leading scientific research and development, to create new product ranges and healthcare solutions that could help transform lives in the future”.
Groundwork to prepare the site has already begun at RB’s Dansom Lane site in the city with construction due to start in the coming weeks. The new facility is due to become operational in 2018.
About RB.: RB (Reckitt Benckiser group of companies) is the world’s leading consumer health and hygiene company. The company has operations in over 60 countries, with headquarters in London, Dubai and Amsterdam, and sales in most countries across the globe. The company employs approximately c. 37,000 people worldwide. Inspired by a purpose to deliver innovative solutions for healthier lives and happier homes, RB is in the top 20 companies listed on the London Stock Exchange. We are the global No 1or No 2 in the majority of our fast-growing categories, driven by an exceptional focus on innovation. Our health, hygiene and home portfolio is led by our global Powerbrands including Nurofen, Strepsils Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Air Wick, Woolite and French’s. Our Powerbrands represent 80% of net revenue. RB is redefining the world of consumer health and hygiene. Our people and unique culture are at the heart of our success. We have a drive for achievement and a passion to outperform wherever we focus, including sustainability where we are targeting a 1/3 reduction in water impact, 1/3 reduction in carbon and 1/3 of net revenue from more sustainable products. We are proud to be Save the Children’s largest global partner, with a new vision to radically reduce one the world’s largest killer of under 5s, diarrhoea. For more information visit www.rb.com.
About M+W Group: Based in Stuttgart/Germany, M+W Group is a leading global high-tech engineering company. Established in 1912, the company operates in more than 30 countries. The M+W Group manages projects of all dimensions on behalf of clients from a range of sectors, including electronics, chemicals and pharmaceuticals, energy and information technology — from semiconductor plants to nanotechnology research centres. The company offers a full range of services from concept and design to turnkey solutions. In the financial year 2015, the M+W Group generated sales of ~3.0 billion euros with around 6,000 employees worldwide. For more information please visit: www.mwgroup.net.
For further information including image and interview requests, please contact:
Nick Glaves at The PR Company
Tel: +44 1482-647575 / +44 7868-359016
E-Mail: nick@tprc.co.uk / media&pr@rb.com
M+W Group Press contact UK:
Alex Goude
Phone: +44 1249-455150
E-Mail: Alex.Goude@mwgroup.net
M+W Group Press contact Global:
Christoph Jag
Phone: +49 711 8804-2193
E-Mail: christoph.jag@mwgroup.net
RB, the world’s leading consumer health and hygiene company, has been present in Hull since 1840. The new £105m development is the single largest investment in the company’s history and represents a significant commitment to RB’s place in the heart of the city.
Designed to be highly sustainable and energy efficient, the CfSE will house a new industry-leading Good Manufacturing Practice (GMP) healthcare development facility. It will feature a number of product development capabilities including analytical, formulation and microbiology laboratories plus a stability testing unit. These will support the creation and testing of cutting-edge innovations focused on meeting consumer’s health needs for leading brands such as Strepsils, Gaviscon and Nurofen.
Sharon James, Senior Vice President, RB R&D described the appointment as a milestone in the history of the Centre for Scientific Excellence. “The new Centre for Scientific Excellence is an ambitious project that will transform our R&D facility in Hull. We’re delighted to announce the appointment of M+W Group. It heralds the beginning of the construction phase of the development, which is incredibly exciting for everyone involved, as well as the city of Hull and the wider Humber region.”
Spencer Baber, UK Managing Director, M+W Group said, “M+W Group is delighted to have been selected as RB’s partner to deliver the new Centre for Scientific Excellence. This new facility will be an innovation hub, enabling RB to carry out industry-leading scientific research and development, to create new product ranges and healthcare solutions that could help transform lives in the future”.
Groundwork to prepare the site has already begun at RB’s Dansom Lane site in the city with construction due to start in the coming weeks. The new facility is due to become operational in 2018.
About RB.: RB (Reckitt Benckiser group of companies) is the world’s leading consumer health and hygiene company. The company has operations in over 60 countries, with headquarters in London, Dubai and Amsterdam, and sales in most countries across the globe. The company employs approximately c. 37,000 people worldwide. Inspired by a purpose to deliver innovative solutions for healthier lives and happier homes, RB is in the top 20 companies listed on the London Stock Exchange. We are the global No 1or No 2 in the majority of our fast-growing categories, driven by an exceptional focus on innovation. Our health, hygiene and home portfolio is led by our global Powerbrands including Nurofen, Strepsils Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Air Wick, Woolite and French’s. Our Powerbrands represent 80% of net revenue. RB is redefining the world of consumer health and hygiene. Our people and unique culture are at the heart of our success. We have a drive for achievement and a passion to outperform wherever we focus, including sustainability where we are targeting a 1/3 reduction in water impact, 1/3 reduction in carbon and 1/3 of net revenue from more sustainable products. We are proud to be Save the Children’s largest global partner, with a new vision to radically reduce one the world’s largest killer of under 5s, diarrhoea. For more information visit www.rb.com.
About M+W Group: Based in Stuttgart/Germany, M+W Group is a leading global high-tech engineering company. Established in 1912, the company operates in more than 30 countries. The M+W Group manages projects of all dimensions on behalf of clients from a range of sectors, including electronics, chemicals and pharmaceuticals, energy and information technology — from semiconductor plants to nanotechnology research centres. The company offers a full range of services from concept and design to turnkey solutions. In the financial year 2015, the M+W Group generated sales of ~3.0 billion euros with around 6,000 employees worldwide. For more information please visit: www.mwgroup.net.
For further information including image and interview requests, please contact:
Nick Glaves at The PR Company
Tel: +44 1482-647575 / +44 7868-359016
E-Mail: nick@tprc.co.uk / media&pr@rb.com
M+W Group Press contact UK:
Alex Goude
Phone: +44 1249-455150
E-Mail: Alex.Goude@mwgroup.net
M+W Group Press contact Global:
Christoph Jag
Phone: +49 711 8804-2193
E-Mail: christoph.jag@mwgroup.net